Soni Jignesh Mohanbhai
Overview
Explore the profile of Soni Jignesh Mohanbhai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kushwaha A, Mohanbhai S, Sardoiwala M, Jaganathan M, Karmakar S, Roy Choudhury S
ACS Biomater Sci Eng
. 2022 Aug;
8(9):3810-3818.
PMID: 36005299
The imbalance in the bone remodeling process with more bone resorption by osteoclasts compared to bone formation by osteoblasts results in a metabolic bone disorder known as osteoporosis. This condition...
2.
Mohanbhai S, Sardoiwala M, Gupta S, Shrimali N, Roy Choudhury S, Sharma S, et al.
Biomater Adv
. 2022 Aug;
136:212796.
PMID: 35929295
Inflammatory Bowel (IBD) is an umbrella term which includes Crohn's Disease (CD) and Ulcerative Colitis (UC). At present, therapies available for management of the UC includes, corticosteroid, immuno-suppressants and antibiotics...
3.
Dev A, Sardoiwala M, Sharma A, Mohanbhai S, Karmakar S, Roy Choudhury S
ACS Med Chem Lett
. 2022 Jul;
13(7):1109-1117.
PMID: 35859882
Neuroblastoma (NB) is an extracranial pediatric tumor with highly invasive growth of cancer biomass and frequent metastases. During the differentiation process in embryonic development, altered epigenetic modifications lead to dysregulated...
4.
Sardoiwala M, Mohanbhai S, Kushwaha A, Dev A, Biswal L, Sharma S, et al.
Life Sci
. 2022 May;
302:120655.
PMID: 35598656
Aims: Inflammatory Bowel Disease is characterised by abdominal pain, diarrhoea, rectal bleeding and weight loss. Sometimes it may leads to severe health complications resulting in death of an individual. Current...
5.
Sardoiwala M, Mohanbhai S, Karmakar S, Roy Choudhury S
Biomater Adv
. 2022 May;
133:112602.
PMID: 35527145
Parkinson's disease (PD) is the second most neurodegenerative disease caused due to synucleinopathy leads to the death of dopaminergic and serotonergic neurons. The approach to reduce synucleinopathy paves the therapeutic...
6.
Dev A, Mohanbhai S, Kushwaha A, Sood A, Sardoiwala M, Roy Choudhury S, et al.
Acta Biomater
. 2021 Dec;
138:576.
PMID: 34887215
No abstract available.
7.
Bhargava A, Dev A, Mohanbhai S, Pareek V, Jain N, Roy Choudhury S, et al.
Sci Total Environ
. 2021 Feb;
772:144797.
PMID: 33578167
Surface functionalization on silver nanoparticles greatly affects the dynamics of protein corona formation. In the present study, the implications of protein pre-coating on corona formation and nanoparticle's physiological stability, cellular...
8.
Kushwaha A, Mohanbhai S, Sardoiwala M, Sood A, Karmakar S, Roy Choudhury S
ACS Appl Mater Interfaces
. 2020 May;
12(23):25633-25644.
PMID: 32453568
Bmi1 is associated with advanced prognosis of acute myeloid leukemia (AML), and polyethylenimine (PEI)-stabilized Bmi1 siRNA-entrapped human serum albumin (HSA) nanocarriers (PEI@HSANCs) were used to protect siRNA from degradation and...
9.
Dev A, Mohanbhai S, Kushwaha A, Sood A, Sardoiwala M, Roy Choudhury S, et al.
Acta Biomater
. 2020 Apr;
109:121-131.
PMID: 32335311
Wound healing remains a healthcare challenge in patients suffering from grave tissue damage due to burn injuries and severe medical conditions like diabetes and ischemia. A repeated wound dressing in...
10.
Kaundal B, Srivastava A, Dev A, Mohanbhai S, Karmakar S, Roy Choudhury S
Mol Pharm
. 2020 Jan;
17(2):604-621.
PMID: 31904978
Acute myeloid leukemia (AML) is a malignant disorder of hematopoietic progenitor cells with a poor prognosis of 26% of patients surviving 5 years after diagnosis. Poor bioavailability and solubility are...